| |
Univariate analysis
|
Multivariate analysis
|
|---|
|
Variable
|
HR (95% CI)
|
p
|
HR (95% CI)
|
p
|
|---|
|
Sex
| | | | |
|
Male
|
Reference
| |
Reference
| |
|
Female
|
0.83 (0.23–2.98)
|
0.774
|
0.44 (0.08–2.37)
|
0.339
|
|
Age (per 1 year increase)
|
1.03 (0.97–1.08)
|
0.357
|
1.02 (0.95–1.09)
|
0.671
|
|
Location
|
0.98 (0.67–1.45)
|
0.932
|
1.09 (0.67–1.78)
|
0.732
|
|
GTV (per 1 cc increase)
|
1.05 (0.99–1.11)
|
0.095
|
1.09 (1.01–1.17)
|
0.028
|
|
BED (α/β = 3) (per 1 Gy increase)
|
0.99 (0.96–1.02)
|
0.592
|
1.02 (0.99–1.06)
|
0.210
|
|
Classification of mean skull HU
| | | | |
|
Hypothetical normal
|
Reference
| |
Reference
| |
|
Hypothetical osteopenia
|
2.90 (0.29–29.30)
|
0.368
|
5.67 (0.40–81.37)
|
0.202
|
|
Hypothetical osteoporosis
|
3.88 (1.02–14.81)
|
0.047
|
5.36 (1.06–27.12)
|
0.042
|
- PTBE, peritumoral brain edema; LINAC, linear accelerator; GTV, gross tumor volume; BED, biologically equivalent dose; HR, hazard ratio; CI, confidence interval; Gy, gray; HU, Hounsfield unit